H.R. 3680 would authorize the Secretary of Health and Human Services (HHS) to establish a grant program to provide funds to eligible entities to develop guidelines and to provide resources for prescribing drugs that reverse opioid overdoses. The bill also would authorize the Secretary of HHS to provide information to prescribers and health care facilities of the Indian Health Service on best practices for prescribing certain drugs to patients with an elevated risk of opioid use disorders. Additionally, H.R. 3680 would reduce amounts authorized to be appropriated for certain existing activities related to bioterrorism and public health emergencies by the Centers for Disease Control and Prevention (CDC). Assuming appropriation actions consistent with the bill, CBO estimates that implementing H.R. 3680 would reduce net discretionary costs by $1 million over the 2017-2021 period.
Pay-as-you-go procedures do not apply because enacting H.R. 3680 would not affect direct spending or revenues. CBO estimates that enacting H.R. 3680 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2027.
H.R. 3680 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would not affect the budgets of state, local, or tribal governments.
